Early On-Set CRC: A Biologically Distinct Threat? - Part II

In part 2 of this video series, Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center, New York, discusses the clinical findings, molecular drivers/alterations, and conducting further research for "Early On-Set Colorectal Cancer: A Biologically Distinct Threat?" presented at the 2021 Great Debates & Updates in Gastrointestinal Malignancies meeting. 

2 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Stay in the know.
OncNet Newsletter